Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Specific gut bacteria are important in early life for healthy immune development.
Dietary LPS can mimic microbial signals and drive gut immune development, with early-life being a critical window for shaping gut immunity.
Dietary intervention and the utilization of D. dubosii offer potential insights for the treatment of brain tumor patients.
The findings of a recent study highlight the importance of understanding skin microbiotas to manage long-term fungal infections in Indigenous communities.
STING activity is important for gut health and that targeting this molecule could offer new treatments for IBD.
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
N-acyl lipids are important, overlooked molecules shaped by diet and gut microbes.
Fiber can influence how well bacteria from a fecal microbiota transplant successfully settle and grow in a person’s gut.
Region-specific microbial transplants may be safer and more effective than standard fecal microbiota transplants.
Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.
